BIOSENSYS: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BIOSENSYS
Largest movements
- Receivables after one year +€297,386
new in 2024: €297,386
- Debts after one year +€1.3m
up €1.3m (+262.1%), from €477,845 to €1.7m
- Other debts -€742,256
down €742,256 (-99.7%), from €744,857 to €2,601
- Profit (loss) carried forward -€87,062
down €87,062 (-10.2%), from -€857,651 to -€944,712
- Revaluation surpluses -€80,000
down €80,000 (-5.6%), from €1.4m to €1.4m
- Reserves +€80,000
up €80,000 (+62.7%), from €127,500 to €207,500
- Gross operating margin -€197,594
down €197,594 (-99.0%), from €199,504 to €1,909
- Other operating charges -€163,686
no longer reported in 2024 (was €163,686)
- Financial income +€8,662
new in 2024: €8,662
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,247,274 | €2,575,590 | +€328,317 | +14.6% |
| Fixed assets | 21/28 | €2,015,714 | €2,020,948 | +€5,234 | +0.3% |
| Tangible fixed assets | 22/27 | €2,015,714 | €2,019,448 | +€3,734 | +0.2% |
| Land and buildings | 22 | €1,992,088 | €2,003,277 | +€11,189 | +0.6% |
| Plant, machinery and equipment | 23 | €23,626 | €16,171 | -€7,456 | -31.6% |
| Financial fixed assets | 28 | - | €1,500 | +€1,500 | |
| Current assets | 29/58 | €231,560 | €554,643 | +€323,083 | +139.5% |
| Amounts receivable after more than one year | 29 | - | €297,386 | +€297,386 | |
| Other amounts receivable | 291 | - | €297,386 | +€297,386 | |
| Stocks and contracts in progress | 3 | €30,855 | €30,855 | = | 0.0% |
| Contracts in progress | 37 | €30,855 | €30,855 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €196,428 | €216,480 | +€20,051 | +10.2% |
| Trade receivables | 40 | €193,979 | €199,030 | +€5,051 | +2.6% |
| Other amounts receivable | 41 | €2,450 | €17,450 | +€15,000 | +612.3% |
| Cash at bank and in hand | 54/58 | €4,276 | €9,922 | +€5,646 | +132.0% |
| Total equity and liabilities | 10/49 | €2,247,274 | €2,575,590 | +€328,317 | +14.6% |
| Equity | 10/15 | €907,849 | €820,788 | -€87,062 | -9.6% |
| Contributions | 10/11 | €200,000 | €200,000 | = | 0.0% |
| Revaluation surpluses | 12 | €1,438,000 | €1,358,000 | -€80,000 | -5.6% |
| Reserves | 13 | €127,500 | €207,500 | +€80,000 | +62.7% |
| Non-distributable reserves | 130/1 | €127,500 | €207,500 | +€80,000 | +62.7% |
| Reserves not available under the articles | 1311 | €127,500 | €207,500 | +€80,000 | +62.7% |
| Profit (loss) carried forward | 14 | -€857,651 | -€944,712 | -€87,062 | -10.2% |
| Amounts payable | 17/49 | €1,339,425 | €1,754,803 | +€415,378 | +31.0% |
| Amounts payable after more than one year | 17 | €477,845 | €1,730,400 | +€1.3m | +262.1% |
| Financial debts | 170/4 | €477,845 | €1,730,400 | +€1.3m | +262.1% |
| Amounts payable within one year | 42/48 | €861,579 | €24,402 | -€837,177 | -97.2% |
| Current portion of amounts payable after more than one year | 42 | €34,350 | - | -€34,350 | |
| Trade debts | 44 | €73,782 | €13,211 | -€60,570 | -82.1% |
| Suppliers | 440/4 | €73,782 | €13,211 | -€60,570 | -82.1% |
| Taxes, remuneration and social security | 45 | €8,590 | €8,590 | = | 0.0% |
| Taxes | 450/3 | €8,590 | €8,590 | = | 0.0% |
| Other amounts payable | 47/48 | €744,857 | €2,601 | -€742,256 | -99.7% |
| Non-recurring operating income | 76A | €129,758 | - | -€129,758 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €96,371 | €97,420 | +€1,049 | +1.1% |
| Other operating charges | 640/8 | €163,686 | - | -€163,686 | |
| Gross operating margin | 9900 | €199,504 | €1,909 | -€197,594 | -99.0% |
| Operating profit (loss) | 9901 | -€60,553 | -€95,510 | -€34,958 | -57.7% |
| Financial income | 75/76B | - | €8,662 | +€8,662 | |
| Recurring financial income | 75 | - | €8,662 | +€8,662 | |
| Financial charges | 65/66B | €127 | €213 | +€86 | +68.2% |
| Recurring financial charges | 65 | €127 | €213 | +€86 | +68.2% |
| Profit (loss) for the period before taxes | 9903 | -€60,679 | -€87,062 | -€26,382 | -43.5% |
| Profit (loss) for the period | 9904 | -€60,679 | -€87,062 | -€26,382 | -43.5% |
| Profit (loss) for the period to be appropriated | 9905 | -€60,679 | -€87,062 | -€26,382 | -43.5% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.